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Surgical site infection (SSI) following spine surgery is a dreaded complication with sig-
nificant morbidity and economic burden. SSIs following spine surgery can be superficial,
characterized by obvious wound drainage or deep-seated with a healed wound. Staphy-
lococcus aureus remains the principal causal agent. There are certain pre-operative risk
factors that increase the risk of SSI, mainly diabetes, smoking, steroids, and peri-operative
transfusions. Additionally, intra-operative risk factors include surgical invasiveness, type of
fusion, implant use, and traditional instead of minimally invasive approach. A high level
of suspicion is crucial to attaining an early definitive diagnosis and initiating appropriate
management.The most common presenting symptom is back pain, usually manifesting 2–
4 weeks and up to 3 months after a spinal procedure. Scheduling a follow-up visit between
weeks 2 and 4 after surgery is therefore necessary for early detection. Inflammatory mark-
ers are important diagnostic tools, and comparing pre-operative with post-operative levels
should be done when suspecting SSIs following spine surgery. Particularly, serum amyloid
A is a novel inflammatory marker that can expedite the diagnosis of SSIs. Magnetic reso-
nance imaging remains the diagnostic modality of choice when suspecting a SSI following
spine surgery. While 18F-fluorodeoxyglucose-positron emission tomography is not widely
used, it may be useful in challenging cases. Despite their low yield, blood cultures should
be collected before initiating antibiotic therapy. Samples from wound drainage should be
sent for Gram stain and cultures. When there is a high clinical suspicion of SSI and in
the absence of superficial wound drainage, computed tomography-guided aspiration of
paraspinal collections is warranted. Unless the patient is hemodynamically compromised,
antibiotics should be deferred until proper specimens for culture are secured.
Keywords: post-surgical spine infection, post-procedural discitis, imaging, risk factors, Staphylococcus aureus,
inflammatory markers
INTRODUCTION
Surgical site infections (SSIs) following spine surgery comprise
superficial and deep infections and were first described as a clin-
ical entity by Turnbull in 1953 (1). Superficial spine infections
are localized to the skin and subcutaneous tissue. On the other
hand, deep infections disseminate under the fascia and encompass
discitis, epidural abscess, and spondylitis; this type of infections
is characterized by inflammation of the intervertebral disks and
associated soft and articular tissues (2).
Although SSIs following spine surgery can be prevented to a
great extent using general measures intended to avert all poten-
tial SSIs, they remain a dreaded complication. Some of these
general preventive approaches include adoption of aseptic tech-
niques, optimization of patient status pre-operatively as well as
intra-operatively, appropriate use of pre-operative antibiotics, and
good post-operative follow-up (3–6). SSIs result in significant
increase in morbidity and incur a substantial cost to the health
care system (7). In one study, each episode of wound infection
following spine procedure contributed to a mean increase in the
cost of care by $4,067 (CI, $1,682.79–6,872.39); (P = 0.0004) com-
pared to a non-complicated case (8). A high index of suspicion
is compulsory in every patient presenting with back pain after
any invasive diagnostic or therapeutic spinal procedure (9). Physi-
cians may sometimes struggle with diagnosing SSI due to a
number of difficulties, including the paucity of physical exami-
nation findings, mimicry of non-infective conditions, presence of
minor symptoms leading to patients not seeking medical atten-
tion, inadequate follow-up strategies in some institutions, and
the previous dependence on plain X-rays that lack sensitivity for
diagnosing SSI (10).
However, the use of a well-defined systematic approach would
help in establishing a definitive diagnosis in a timely manner. This
would be based on a comprehensive history, thorough physical
examination, detailed laboratory studies, blood cultures, and cul-
tures of wound or computed tomography (CT)-guided aspirate
material, and imaging studies.
In this paper, we attempt to provide a comprehensive review
on the diagnostic approach to SSIs following spine surgery. We
discuss the incidence of SSIs based on type of procedure, detailing
the factors that place patients at increased risk for infection and
highlighting the spectrum of involved pathogens. We also review
clinical, laboratory, and imaging techniques in the diagnosis of SSI,
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addressing some of the controversies. Treatment of SSIs is beyond
the scope of this article and will not be reviewed here.
EPIDEMIOLOGY
The reported incidence of SSIs following spine surgery ranges from
0.5 to 18.8% (11–19). Such wide-ranging results from different
reports are most probably due to significant variations in oper-
ative factors such as the use of implants, case complexity, and
the surgical approach itself. Additionally, in some cases, the disci-
tis may be self-limited and may not be reported to the surgeon,
whereas in other cases, patients may suffer from fulminant sepsis
with abscess development.
A crucial need exists for documentation of an exact incidence
of SSIs at every center depending on the surgical procedure. This
will direct pre-operative patient counseling, improve quality of
care, enhance the effectiveness of infection control measures, and
potentially alleviate medico-legal concerns.
Table 1 summarizes studies that have looked at the incidence
of SSI following spine surgery and that provided data on type of
surgery and type of infection. The largest study by Smith et al.
included a total of 108,419 patients from 2004 to 2007. The pri-
mary endpoint of the study was to estimate the incidence of SSIs
and the secondary endpoint was to assess risk factors for infection
(20). Infections were deemed to be superficial in 0.8% and deep in
1.3% of cases. Other studies in heterogeneous surgical conditions
between 2001 and 2012 (Table 1) reported infection rates from
0.15 to 7.2% (20–33).
Infection rates vary greatly according to type of initial sur-
gical intervention (Table 2) (16, 20, 34). Notably, surgeries for
spinal trauma are associated with the highest SSI rates, reported
to be 9.4% in one study (20). Patients undergoing spine surgeries
for metastatic tumor and acute osteodiscitis constitute two other
subgroups with high infection rates of around 5%. On the other
hand, surgeries for degenerative disease have the lowest reported
Table 1 | Prospective and retrospective clinical studies on incidence of SSI incidence following spine surgery (20–33).
Reference Study design Type of interventional
procedures (%)
Type of SSI considered
in the study
Number of total
study patients
SSI rate (%)
(20) Retrospective review of
prospectively collected data
Invasive (87); minimally
invasive (13)
Superficial or deep 108, 419 6.7
(21) Retrospective review of
prospectively collected data
Decompressive (78);
instrumented (20);
intra-dural (2)
Superficial or deep 1,274 0.22
(22) Retrospective data review Decompressive (89);
instrumented (1.4)
Superficial or deep 663 0.15
(23) Retrospective case–control study Decompressive (27.4);
instrumented (72.5)
Superficial or deep 2,316 2.0
(25) Retrospective data review Instrumented fusions (100) Deep only 1,980 3.7
(24) Case–control study Laminectomy (100) Superficial or deep 6,365 1.0
(28) Retrospective data review Instrumented posterior (82);
anterior (18)
Deep only 326 4.3
(26) Retrospective data review Decompressive (60);
instrumented (40)
Deep only 1,133 0.7
(27) Retrospective data review Instrumented posterior
interbody fusion (100)
Deep only 111 7.2
(33) Prospective case–control study Mixed decompressive and
instrumented
Superficial or deep 997 2.7
(29) Retrospective case–control Mixed decompressive and
instrumented
Deep only 1,095 4.4
(30) Retrospective case–control study Mixed decompressive and
instrumented
Superficial or deep 1,918 2.8
(31) Prospective surveillance study Laminectomy Nosocomial infection 37,137 0.9–2.6
(31) Prospective surveillance study Spinal fusion Nosocomial infection 21,491 1.2–7.2
(32) Retrospective data review Instrumental lumbar
fusion (100)
Deep only 817 3.2
(34) Retrospective data review Mixed decompressive
and instrumented
Deep only 2,391 1.9
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Table 2 | Rate of SSI following spine surgery by type of surgery.
Type of surgery (reference number) Rate of SSI (%)
Trauma (20) 9.4
Acute discitis (20) 5.1
Metastatic tumor (20, 34) 5.1
Kyphosis (20) 4.2
Scoliosis (20) 3.7
Elective spinal surgery (20) 3.7
Implant revision (20) 3.2
Non-minimally invasive (20) 2.4
Degenerative disease (20) 1.4
Minimally invasive approach (16, 20) 0.5
infection rate of 1.4%. Moreover, minimally invasive spinal pro-
cedures seem to be associated with a much lower infection rate
than open procedures (0.5 vs. 2.4%, P = 0.001) (20). In the study
by Smith et al., the overall rate of infection among adults varied
depending on the location of spine surgery. The highest rates were
for thoracic procedures (2.1%), followed by lumbar (1.6%) and
cervical procedures (0.8%) (20). Other factors that affect infec-
tion rates include the nature of the surgical procedures. Spinal
fusion had a 33% higher risk of infection than procedures without
fusion (20). In addition, infections rates vary depending on the
approach to spinal fusion. For instance, cases with anterior fusion
only showed significantly lower infection rates (0.6%) compared
to the overall rate of infection associated with fusion cases. This
lower infection rate with the anterior approach may be explained
by less extensive muscle dissection for bone exposure and the bet-
ter vascularity of the anterior spine. For the other types of fusion,
significantly higher infection rates were reported. These included
combined anterior–posterior fusions (3.2%), posterolateral-only
fusions (3.0%), and interlaminar facet-only fusions (2.8%) (20).
The presence of implants is another factor that significantly
increases SSI risk. Cases with instrumentation have resulted in
a 28% higher infection rates than cases without implants (20).
Implants provide an avascular surface for the bacteria to form
a biofilm and constitute a nidus for microbial growth, hence
escaping antibiotic activity and the host immune system.
In addition, revision cases are associated with a 65% higher
rate of infection compared with primary cases. This significant
increase in infection rates was even more evident for deep wound
(2.2 vs. 1.2%) compared with superficial wound infections (1.1 vs.
0.8%) (20).
SPECIFIC RISK FACTORS FOR SSI DEVELOPMENT
The incidence of SSIs is determined by both pre-operative and
intra-operative risk factors. Several pre-operative patient factors
(Table 3) have been incriminated in significantly increasing SSI
risk. Diabetes (35) and cigarette smoking (28) for instance, are
both associated with tissue ischemia and small vessel damage,
predisposing to increased risk of infection. In addition, obesity
constitutes a risk factor for SSI due to the thick layer of adipose
tissue in obese patients, characterized by poor perfusion and pre-
senting a large space for potential infective processes (28). Other
identified peri-operative risk factors for SSI include steroid use
Table 3 | Surgical site infection pre-operative risk factors (28, 34–38).
Diabetes
Cigarette smoking
Obesity
Steroid use
Alcohol abuse
Extremes of ages
Peri-operative transfusion of blood products
Table 4 | Intra-operative factors associated with high risk for SSI
(20, 28, 36, 39–44).
Surgical invasiveness index
Type of fusion performed
Implants use
Revision intervention (compared to primary intervention)
Traditional open approach (compared to minimally invasive approach)
Site of surgery (dorsal surgeries with highest infective risk compared
to cervical and lumbar locations)
Omission of drain usage post spine surgery
Administered fraction of inspired oxygen less than 50%
Operative duration above 3 h
Instrumentation alloy from stainless steel (compared to titanium use)
(23, 36), alcohol abuse (28, 37), extremes of ages (28, 36, 37), and
transfusion of blood products (38).
In addition to pre-operative risk factors, multiple surgical fac-
tors have been assessed for their association with the occurrence
of spinal infections (Table 4) (20, 28, 34–44).
The assessment of both pre-operative and intra-operative risk
factors is mandatory according to best clinical practice. This would
aid physicians in their operative approach choices and would allow
closer follow-up for high-risk patients. We suggest the prospective
development of an SSI risk score that would be inclusive of the
relevant risk factors (Tables 3 and 4). There is a need to conduct
studies aiming at generating this risk score based on reliable evi-
dence. This score would be used as a tool to limit the ambiguity
in the management and follow-up of patients undergoing spine
surgery. The NHSN SSI standardized infection ratio (SIR) risk
adjustment model can serve as a guide for the development of a
specific one for spine surgeries (45).
MICROBIAL ETIOLOGY
Confirming the microbial etiology of SSI following spine surgery
is of paramount importance to appropriately guide antimicro-
bial therapy. This is specifically important in the era of increasing
antimicrobial resistance. Empirical antibiotic therapy is highly dis-
couraged before obtaining the proper specimens for cultures (46,
47). Blood and wound cultures are recommended in patients pre-
senting with suspected SSIs. When a deep collection is localized,
obtaining a CT-guided specimen for Gram stain and culture is
highly recommended. When surgical intervention is indicated and
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removal of implants is done for curative treatment, vortexing and
sonication of the extracted implants to release biofilm-embedded
organisms have shown an improvement in the diagnostic yield.
Cultures from sonicated spinal implants have reported sensitivity
and specificity rates of 93 and 97%, respectively, for confirming
the causative pathogen (48).
Surgical site infection following spine surgery usually occurs
through direct inoculation during the surgical procedure. The
other two possible routes of infection are hematogenous spread
and early post-operative contamination. Staphylococcus aureus
remains the leading agent of SSI responsible for around 50% of
cases, although estimates in various studies range from as low
as 12–65% (12, 28, 48–50). Additional common causes of SSI
include coagulase-negative staphylococci, mainly Staphylococcus
epidermidis, mostly associated with implanted spinal prosthesis. In
addition, Gram-negative organisms can be encountered, includ-
ing Pseudomonas aeruginosa, Escherichia coli, and Proteus species
(9). Gram-negative organisms are more likely to occur in cases
of hematogenous seeding, and in lower lumbar surgical inter-
ventions due to proximity to the perianal area. Additional risk
factors for SSI with Gram-negative bacteria include bladder or
fecal incontinence, a previous history of long hospital admission
and a posterior lumbosacral surgical approach (51). A history of
intravenous drug use has also been associated with an increased
risk of Gram-negative pathogens (9, 52). Recognizing all these
risk factors would help in guiding empirical antimicrobial therapy
pending culture results.
More recently anaerobic microorganisms such as Propionibac-
terium acnes, part of the normal skin flora, have been increasingly
reported to cause various orthopedic-related SSIs including spine
surgeries (53–55).P. acnes is difficult to detect in patients undergo-
ing spinal surgery with instrumentation (56). Patients withP. acnes
infection have a typical clinical presentation. They are usually in
the fifth or sixth decade of life. They present with low-grade or
no fever following a posterior spinal fusion and instrumentation
and often present with a late (more than 30 days) post-surgical
back pain as a sole complaint (55). Other than its usual indolent
and delayed post-procedural clinical presentation, two additional
reasons may explain the under-diagnosis of P. acnes SSI. First, this
organism is considered as a low virulence skin organism, and thus
is ignored in some cases to be the causative agent in SSI. Second,
P. acnes is a slow growing microorganism that requires extended
incubation time for growth (52). Thus, when this organism is
suspected, several deep tissue specimens should be obtained and
cultured for extended periods.
DIAGNOSIS
Establishing the diagnosis of SSI can be very challenging, and
a high index of suspicion should always be maintained for any
patient presenting with back pain within a window period of
3 months after the procedure. Figure 1 represents an algorithm
for a diagnostic approach to suspected surgical spine infections
and is detailed in the following sections. A number of difficulties
may delay the confirmation of SSI. Although the usual duration
between the invasive procedure and the occurrence of the infec-
tion ranges from 2 to 30 days (57), many indolent organisms like
P. acnes, Serratia marcescens, diphtheroids, and coagulase-negative
staphylococci classically present after 30 days (34). In addition,
patients may not seek early medical attention since infection may
present initially with minimal back pain as the only clinical finding
and the lack of prompt medical follow-up after the procedure may
therefore aggravate the problem (28, 52).
There remains a need for large multi-center clinical studies to
address the optimal diagnostic approach for SSI. In this section,
we will analyze currently available diagnostic modalities and the
controversies that surround them.
CLINICAL PRESENTATION
The most common presenting symptom for SSI following spine
surgery is back pain, usually 1 month after the procedure with a
range of 2 days to over 3 months post-intervention (57). Studies
focusing on spinal procedures with instrumentation showed that
the onset of SSI is more delayed in this category of patients, with
a mean time to SSI diagnosis of 14 months, thus underlying the
need for long-term follow-up subsequent to instrumented spinal
procedures (25). The pain is characteristically localized, continu-
ous, and not relieved by pain medications. It can radiate to the hip,
leg, scrotum, groin, abdomen, or perineum. It has a slow, insidi-
ous onset, which can cause diagnosis to be delayed. It could appear
after a pain-free interval for as long as 3 months (29). Other char-
acteristic clinical features are wound drainage and constitutional
symptoms such as fever, present in 40% of the cases, fatigue, and
weight loss (28, 57).
Additionally, physical examination may reveal localized tender-
ness, warmth, erythema, and edema at the site of surgery with or
without purulent wound drainage (9). Purulent wound drainage
occurs in around two-third of SSIs with instrumentation and is
the most frequent indicative sign of instrumented spine surgery
infections (48).
Deep infections present more commonly with constitutional
symptoms, and in rare cases, patients might suffer from severe
sepsis and end organ failure. Deep infections often lack impressive
superficial features making their diagnosis solely presumptive.
INFLAMMATORY MARKERS
The most frequently used laboratory tests for both the diagnosis
and follow-up of patients suspected to have SSI following spine
surgery are: white blood cell count (WBC), differential erythro-
cyte sedimentation rate (ESR), and C-reactive protein (CRP). The
WBC is elevated in less than 50% of SSI cases, thus making it
an unreliable diagnostic marker (58). Although CRP and ESR are
highly sensitive in the detection of any SSI, many barriers face their
use in daily practice. ESR and CRP levels increase post-operatively
rendering the differentiation between infected and non-infected
patients problematic in the early post-operative window period.
In fact, CRP levels possess low positive predictive values (31%)
in the diagnosis of SSI (59). For instance, CRP levels peak on
day 3 and decrease to normal baseline between days 10 and 14
post-operatively (60). On the other hand, ESR levels are highest at
around 14 days and do not normalize until approximately 6 weeks
after surgery. The earlier normalization of CRP and its higher sen-
sitivity in diagnosing SSI compared to ESR (95 vs. 80%) make it
a more useful tool (60–64). In cases of suspected SSI, it would
be very useful to compare CRP levels at day 7 to those on day
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FIGURE 1 | Algorithm for rapid diagnosis and management of post-surgical spine infections.
3; a detected elevation on day 7 would raise the suspicion for an
infective process.
Some factors have been reported to influence CRP level. These
include the amount of blood loss, the pre-operative CRP level,
and the location of spinal intervention. For example, surgeries
on the lumbar region were found to be associated with higher
post-surgical levels of CRP compared to procedures involving
other regions (62).
In view of these uncertainties surrounding the use of inflamma-
tory markers as diagnostic tools for SSI, additional tools are desir-
able to distinguish between infected and non-infected patients in
the post-operative period.
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Serum amyloid A (SAA), conventionally considered for its
role in the pathogenesis of amyloid A-type amyloidosis, has
been recently studied for its immunological activities, specifi-
cally its function in activating Toll-like receptor (TLR) 2 and
TLR4, class B scavenger receptor CD36. A study by Deguchi
et al. compared the serum levels of CRP and SAA after poste-
rior approach spine surgery. The authors found that both markers
achieved their highest levels on day 3. Although the levels later
decreased, the rate of normalization of SAA was faster com-
pared to CRP. SAA has a short half-life of 50 min compared to
5–7 h for CRP. This distinctive rapid decrease in SAA in non-
infected cases is very helpful in eliminating one of the controversies
surrounding the diagnosis of early SSI (65). Another remark-
able finding in this study was that with the administration of
corticosteroids, while the serum level of CRP decreases or even
normalizes, that of SAA is not altered. Additionally, SAA lev-
els did not vary with gender or age, and the marker preserved
reactivity in patients with rheumatoid arthritis receiving corti-
costeroid therapy. Therefore, SAA can be considered a better
inflammatory marker in the assessment of SSI following spine
surgery (65).
Other inflammatory markers such as procalcitonin have been
less promising in the diagnosis of SSI (66). One study compared
the level of procalcitonin in 17 patients with spondylodiscitis and
18 patients with herniated disks and found no elevation in either
group.
Our recommended approach for a comprehensive follow-up
of patients undergoing invasive spinal procedures is using inflam-
matory markers with a combined comparative measurement of
WBC, CRP, and SAA pre-operatively, at day 1, 3, 7, and 14 and
upon presentation with suspected SSI (65).
IMAGING
Imaging is considered a key element for the diagnosis and follow-
up of SSI following spine surgery. Even though magnetic resonance
imaging (MRI) remains the technique of choice, plain X-ray has
always been the first to be ordered when suspecting an SSI. How-
ever, this imaging lacks sensitivity in detecting SSI, which can cause
delays in the establishment of a definitive diagnosis (12, 67). In
fact, post-operative plain radiographs performed up until 4 weeks
post index procedure, are expected to show normal or unchanged
spinal structure compared to pre-operative images (2, 67). The first
pathologically defining change to appear between the fourth and
sixth weeks post-operatively is a decrease in intervertebral height.
Other plain radio film manifestations, including osteolysis, defor-
mity, and endplate destruction, are only expected to appear after
6 weeks (2, 67).
As for CT scanning, interest was lost in this technique after
the advent and widespread availability of MRI. However, CT scan
imaging can be used to assess bony destruction and spinal stability
with great precision (2, 9). It can aid in planning transcutaneous
aspiration and in the surgical approach and technique.
Radionuclide imaging has shown higher sensitivity and earlier
detection of SSI compared to CT scanning and X-ray imaging. For
instance, Gallium 67 scanning can show focal increased uptake
areas suggestive of infection with high sensitivity and specificity
of 89 and 85%, respectively (2, 68, 69). Moreover, it is estimated
that the interval for the appearance of diagnostic radiological signs
of SSI is shortened with Gallium 67 compared to Technetium 99
scanning (2, 68, 69), rendering Gallium 67 the preferred agent for
early detection of SSI radiological changes.
Magnetic resonance imaging is currently the most appropri-
ate imaging to be performed as a first step when suspecting SSIs
(70, 71). MRI is both the most sensitive (93%) and specific (96%)
technique to evaluate SSIs following spine surgery (72, 73). The
diagnostic features of SSI can be detected as early as days 3–5
post-operatively. Characteristic findings include diminished disk
height, vertebral body, and disk space, decreased intensity on
T1-weighted images, increased signal intensity on T2-weighted
imaging secondary to edema, and endplate definition loss. These
vertebral disk changes are accompanied by increased bone marrow
intensity signaling due to edema (74).
Early in the infection process, short tau inversion recovery
(STIR) sequences offer higher signal intensity to help differen-
tiate the infected area from the normal spine, but with a drawback
of inferior anatomic detail (73). Although MRI remains the imag-
ing of choice, many limitations hamper its role in the diagnosis
of SSI. Diagnostic findings depend on many technical parame-
ters, and artifacts from implants may hinder the interpretation of
results (76, 77). In addition, some degenerative or inflammatory
non-infectious diseases may simulate spinal infection leading to
a false positive result (75, 76). Moreover, an important limitation
involves the follow-up of patients with SSIs. There is often no
noted difference in the MRI between patients who have shown
clinical improvement and those who did not (77). Thus, the clin-
icians’ interpretation of follow-up MRI results should focus on
soft tissue rather than bony findings, keeping in mind that no sin-
gle parameter in MRI results is significantly correlated with the
clinical status variation (77).
Many studies have been recently undertaken to define the imag-
ing technique that will resolve the above-mentioned controversies
and limitations surrounding the radiological diagnosis of SSI fol-
lowing spine surgery. 18F-fluorodeoxyglucose-positron emission
tomography (FDG-PET) imaging is one modality that has lately
shown utility in patients with suspected SSI (76). In a prospective
cohort study that assessed over 300 patients, Ohtori et al. found
that a definitive diagnosis of SSI was achieved more often when
18FDG-PET was utilized (78). This was reported specifically in
patients with spinal infections presenting as Modic type 1 signal
on MRI, which made the distinction between common Modic
changes and SSI challenging (78, 79). The benefit of 18FDG-PET
imaging is its usefulness in the work-up of patients with metallic
implants, since it is not affected by artifacts. In fact, 18FDG-PET
imaging is characterized by high sensitivity and specificity and can
provide results within 2 h with a resolution of up to 4–5 mm. In
addition, it entails a relatively low exposure to radiation and helps
in distinguishing between initial spondylodiscitis and degenera-
tive changes in the vertebral body endplate (79). One limitation
of this technique is that it is difficult at times to distinguish an
infectious process from a malignancy (80). However, in the right
clinical setting, this is not expected to be an issue in the post-
operative period. Unfortunately, due to its high cost and limited
availability, the use of this technique remains limited, and it is indi-
cated as a second line option for complicated cases with significant
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delay in the establishment of a definitive diagnosis, or when MRI
is contraindicated (78–81).
ETIOLOGICAL DIAGNOSIS
The isolation of a specific pathogen is of crucial importance in the
diagnosis and management of SSIs following spine surgery. Blood
cultures (two to four sets) constitute the simplest procedure to
detect the pathogen. When the blood culture yields a highly path-
ogenic organism such as S. aureus,P. aeruginosa, and no other sites
of infections are obvious, then this is diagnostic of the causative
agent. However, blood cultures lack both sensitivity and specificity
in detecting the pathogen (82).
Superficial infections do not pose significant controversies
and their diagnosis is more obvious than that of deep infec-
tions. In superficial spine infections, Gram stain and culture
of wound swabs or aspirated fluid are recommended. Although
very easy to perform, wound swab cultures lack specificity due
to contamination by normal skin flora. In contrast, deep-seated
spine infections require CT or fluoroscopic-guided deep aspira-
tion from the infected area. This has shown a low diagnostic
yield of around 40% when compared to cultures from intra-
operative infected tissue, which remains the most reliable method
of pathogen detection. Previous use of antibiotics is the main rea-
son for the low diagnostic yield of fluoroscopic-guided aspiration
(82–85). However, since the procedure has already been estab-
lished to be both safe and minimally invasive, it should be done
in all patients with deep-seated infections with negative blood
cultures.
Three main recommendations may help in improving the diag-
nostic yield and avoiding false negative cultures. First, the use of
a large bore needle is encouraged (86). Second, histopathologi-
cal examination should be requested as an adjunct to cultures if
adequate tissue can be safely obtained, since this can help iden-
tify pyogenic from granulomatous changes in tissues. The use of
additional staining for fungi and mycobacteria is highly advised,
especially with previous negative culture results (87–90). Third,
a delay in antibiotic therapy is recommended in order to achieve
a better culture yield of aspirated specimens (52). This should
be balanced with potential consequences of delayed treatment. In
patients with normal neurologic examination and normal hemo-
dynamic status and who had been started on antibiotics before
the performance of CT-guided aspiration, withholding therapy
for 1 week before performing the procedure is advisable. How-
ever, for patients with neurological compromise, broad-spectrum
empiric antibiotic therapy and immediate surgical intervention
are warranted (91).
These recommendations are intended to maximize the yield of
cultures obtained from CT-guided aspirations. However, if cul-
tures are negative, the patient’s neurological and hemodynamic
status is of pivotal importance in determining the best next step
in clinical practice. Repeating the percutaneous aspiration is rec-
ommended if the patient has a normal neurological evaluation, is
hemodynamically stable, and has no major underlying morbidities
(92, 93). Conversely, in patients who present with deteriorating
general or neurological status, rapid intervention is crucial to
improve patient outcome. Surgical intervention is recommended,
along with obtaining cultures of intra-operative specimens, since
this has shown increased diagnostic yield even if minimally
invasive techniques had been used for sampling (94–96).
Two techniques have improved the yield of microbiologic
confirmation of the offending organism. First, the use of novel
DNA microarrays and polymerase chain reaction (PCR) molecu-
lar amplification techniques of aspirated or sampled tissues and
fluid during surgery or percutaneous aspiration and biopsy have
shown high sensitivity and specificity and could be instrumen-
tal in defining the etiological diagnosis of SSI (97–102). This
technique offers a particular advantage in patients with prior
antibiotic use. In addition to classical bacterial pathogens, PCR
amplification can effectively detect mycobacterial species. Given
the extremely elevated morbidity and neurological dysfunction
associated with untreated spine infections, these molecular tech-
niques may help in obtaining a quick definitive diagnosis of SSI
and prompt an earlier initiation of targeted antibiotherapy (97–
102). However, susceptibility testing cannot be obtained through
molecular testing, highlighting the superiority of cultures.
Second, vortexing and sonication of retrieved spinal implants
to disrupt the biofilms has been recommended. Even though this
technique is not widely available for daily practice, it has shown
a sensitivity of 93% and a specificity of 97% in the isolation of
pathogens involved in SSIs following spine surgery (48). Addi-
tional efforts are needed to increase availability, accessibility, and
utilization of these new methods (48).
CONCLUSION
Surgical site infection following spine surgery is a major cause
of increased morbidity following spine interventions and an
immense burden on the health care system. A high index of suspi-
cion should be kept in the first 3 months after the procedure. The
diagnosis is usually suspected based on the symptoms and physi-
cal exam findings. However, a number of laboratory and imaging
techniques are available to speed up the confirmation of the diag-
nosis and the recovery of the offending organisms, which would
allow early targeted therapy.
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